Clinical Trial: A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With Moderate-to-severe Atopic Dermatitis

U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07211542) titled 'A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With Moderate-to-severe Atopic Dermatitis' on Sept. 30.

Brief Summary: This trial was designed to evaluate the efficacy and safety of SHR-1905 in patients with moderate-to-severe atopic dermatitis.

Study Start Date: Nov., 2025

Study Type: INTERVENTIONAL

Condition: Moderate-to-severe Atopic Dermatitis

Intervention: DRUG: SHR-1905 Injection

SHR-1905 injection.

DRUG: SHR-1905 Injection Blank Preparation

SHR-1905 injection blank preparation.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd

Disclaimer: Curated by HT ...